Testopel
NDC 43773-1001
Product Information
Testopel is a ANDA-approved product labeled by Slate Pharma. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 43773-1001 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 43773-1001?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TESTOSTERONE (UNII: 3XMK78S47O)
- TESTOSTERONE (UNII: 3XMK78S47O) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STEARIC ACID (UNII: 4ELV7Z65AP)
- POVIDONE K30 (UNII: U725QWY32X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 318240 - testosterone 75 MG Subcutaneous Pellet Drug Implant
- RxCUI: 318240 - testosterone 75 MG Drug Implant
- RxCUI: 318240 - testosterone 75 MG Implant Pellet
- RxCUI: 404405 - TESTOPEL 75 MG Subcutaneous Pellet Drug Implant
- RxCUI: 404405 - testosterone 75 MG Drug Implant [Testopel]
* Please review the full disclaimer at the bottom of this page.